Induction Treatment Followed by Immunosuppression Withdrawal in Liver Transplantation: A Comparative Trial

NCT00436722 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

72

Enrollment

OTHER

Sponsor class

Stopped Experimental arm (induction + low dose tacrolimus) not effective.

Conditions

Liver Diseases

Interventions

DRUG: ATG (Fresenius Biotech)

Sponsor

Hospital Clinic of Barcelona

Collaborators

[object Object]
[object Object]